 |
 |
 |
||||||
 |
||||||||
 |
 |
 |
 |
|||||
 |
 |
 |
|
|||||
|
|
|
|
|
|
|
|
|
 |
 |
|
 |
2006 Press Archive | |
|
2005 Press Archive | |
|
2003 Press Archive | |
|
2002 Press Archive | |
|
2001 Press Archive | |
|
2000 Press Archive | |
 |
|
|
Press Releases - 2004
2004 Press Releases
January 6
Sangamo Biosciences Announces Publication in Cancer Research of ZFP Repression of VEGF-A
January 14
Sangamo Biosciences Announces Presentation at the Seidler Companies Incorporated Life Science Conference
February 11
Sangamo Biosciences’ Partner Edwards Lifesciences Files Investigational New Drug Application for Phase I/II Clinical Trial
February 11
Sangamo Biosciences Reports 2003 Fourth Quarter and Year-End Financial Results (460k PDF)
February 18
Sangamo Biosciences To Webcast Presentation At The Bio Ceo & Investor Conference 2004
February 25
Sangamo Biosciences to Webcast Presentation at the Wall Street Analyst Forum 51st NYC Analyst Conference
March 8
Sangamo Biosciences Announces Presentation at the JMP Securities Third Annual Research Conference
April 23
Sangamo Biosciences Announces First Quarter 2004 Conference Call And Webcast
April 29
Sangamo Biosciences Reports 2004 First Quarter Financial Results (465k PDF)
May 4
Sangamo Biosciences Receives $2 Million Advanced Technology Program Grant to Expand ZFP TF Technology
May 17
Sangamo Biosciences to Make 16 Presentations at the 7th Annual Meeting of The American Society of Gene Therapy
June 3
Sangamo Biosciences to Present Update on Preclinical Programs in Pain and Stem Cell Research at the 7th Annual Meeting of The American Society Of Gene Therapy
June 4
Sangamo Biosciences Announces Preclinical Animal Efficacy Data for Diabetic Neuropathy Program
June 4
Sangamo Biosciences Hosts Scientific Symposium Highlighting Zinc Finger Technology and ZFP Therapeutic™ Programs
June 5
Sangamo Biosciences Presents Data Demonstrating Correction Of Endogenous Gene at the 7th Annual Meeting of The American Society Of Gene Therapy
June 7
Sangamo Biosciences Provides Summary Of Data Presented at the 7th Annual Meeting of The American Society Of Gene Therapy
June 8
Sangamo Biosciences Announces Presentations at Bio 2004
July 14
Sangamo BioSciences Announces Second Quarter 2004 Conference Call and Webcast
July 21
Sangamo BioSciences Reports 2004 Second Quarter Financial Results (470k PDF)
August 10
Sangamo BioSciences Announces the Appointment of Dale Ando, M.D. as Vice President, Therapeutic Development and Chief Medical Officer
September 8
Sangamo BioSciences to Webcast Analyst Meeting Tuesday, September 14, 2004
September 14
Sangamo BioSciences Updates Investors on Status of Latest Developments in ZFP Therapeutics Programs
September 24
UBS Global Life Sciences Conference to Webcast Sangamo Presentation
September 30
Sangamo BioSciences Announces Research Collaboration With LifeScan to Develop Treatment for Diabetes
October 11
BIO Emerging Company Investor Forum to Webcast Sangamo Presentation
October 19
Sangamo BioSciences Announces Publication in Circulation of Data From ZFP Angiogenesis Program
October 21
Rodman and Renshaw Techvest Annual Healthcare Conference to Webcast Sangamo Presentation
October 27
Webcast Alert: Sangamo BioSciences, Inc. Announces Webcast of Third Quarter, 2004 Teleconference
November 3
Sangamo BioSciences Reports 2004 Third Quarter Financial Results (490k PDF)
November 30
Sangamo BioSciences Granted U.S. Patent Covering Protein Formulations of Engineered Zinc Fingers
December 7
Sangamo BioSciences Selected as a Technology Pioneer for 2005 by the World Economic Forum
December 15
Sangamo BioSciences Announces Expansion of Research Collaboration With LifeScan to Develop Treatment for Diabetes
|
Contact |  |
Careers | |
Site Map | |
Legal | |
Glossary | |
|
|
|
|
|
|
|